These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6938189)

  • 41. Heart conduction disturbances and cardiovascular collapse after disopyramide and low-dose metoprolol in a patient with hypertrophic obstructive cardiomyopathy.
    Pernat A; Pohar B; Horvat M
    J Electrocardiol; 1997 Oct; 30(4):341-4. PubMed ID: 9375912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disopyramide-induced syncope.
    Tri TB
    Am J Cardiol; 1979 Aug; 44(2):391-2. PubMed ID: 463780
    [No Abstract]   [Full Text] [Related]  

  • 43. Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
    Hayashi Y; Ikeda U; Hashimoto T; Watanabe T; Mitsuhashi T; Shimada K
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):672-4. PubMed ID: 10234723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disopyramide.
    Koch-Weser J
    N Engl J Med; 1979 Apr; 300(17):957-62. PubMed ID: 431563
    [No Abstract]   [Full Text] [Related]  

  • 45. Respiratory difficulty after use of disopyramide.
    Porterfield JG; Antman EM; Lown B
    N Engl J Med; 1980 Sep; 303(10):584. PubMed ID: 7402225
    [No Abstract]   [Full Text] [Related]  

  • 46. [Letter: Syncopes through the inversion of points in connection with the absorption of disopyramide].
    Casedevant B; Sabaut D; Clementy J; Dallocchio M
    Nouv Presse Med; 1975 Oct; 4(32):2339. PubMed ID: 1178509
    [No Abstract]   [Full Text] [Related]  

  • 47. [A case of atypical ventricular tachycardia induced by disopyramide].
    Yamaguchi A; Kato T; Shimada E; Matsumoto K; Asano H; Yamane Y; Watanabe M
    Kokyu To Junkan; 1984 Apr; 32(4):421-4. PubMed ID: 6463421
    [No Abstract]   [Full Text] [Related]  

  • 48. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
    Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Torsade de pointes.
    Santinelli V; Chiariello M; Condorelli M
    Circulation; 1982 Jul; 66(1):250-1. PubMed ID: 7083516
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    De Backer M; Stoupel E; Kahn RJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Torsade de pointes" - A unique ventricular arrhythmia report of eight cases and review of the literature.
    Chia BL; Ee B; Oh V
    Singapore Med J; 1981 Aug; 22(4):219-23. PubMed ID: 7323830
    [No Abstract]   [Full Text] [Related]  

  • 55. Disopyramide in patients with ventricular premature beats: an experimental model and preliminary results.
    Hohansson BW; Persson S
    J Int Med Res; 1976; 4(1 Suppl):96-9. PubMed ID: 1026538
    [No Abstract]   [Full Text] [Related]  

  • 56. Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapy.
    Rothman MT
    Br Med J; 1980 Mar; 280(6218):922-3. PubMed ID: 7388371
    [No Abstract]   [Full Text] [Related]  

  • 57. Disopyramide in ventricular tachycardia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 200(3):209-13. PubMed ID: 970227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of intravenous and oral disopyramide on paroxysmal atrioventricular nodal tachycardia.
    Brugada P; Wellens HJ
    Am J Cardiol; 1984 Jan; 53(1):88-92. PubMed ID: 6362389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias.
    Le Corre P; Gibassier D; Descaves C; Sado P; Daubert JC; Le Verge R
    J Clin Pharmacol; 1989 Dec; 29(12):1089-96. PubMed ID: 2482304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. QT prolongation and torsade de pointes ventricular tachycardia produced by Ketanserin.
    Aldariz AE; Romero H; Baroni M; Baglivo H; Esper RJ
    Pacing Clin Electrophysiol; 1986 Nov; 9(6):836-41. PubMed ID: 2432486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.